A potential new approach for the treatment of schizophrenia

By: Vanderbilt University Research News

Previous
Previous

Vanderbilt inks collaboration with precision neuroscience company Neumora to continue development of investigational treatment for neuropsychiatric disorders

Next
Next

Jeffrey Conn, founding director of Warren Center for Neuroscience Drug Discovery, named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics